299 related articles for article (PubMed ID: 35230420)
1. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Sheehan JL; Jacob J; Berinstein EM; Greene-Higgs L; Steiner CA; Berry SK; Shannon C; Cohen-Mekelburg SA; Higgins PDR; Berinstein JA
Inflamm Bowel Dis; 2022 Dec; 28(12):1904-1914. PubMed ID: 35230420
[TBL] [Abstract][Full Text] [Related]
2. Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Niccum B; Moninuola O; Miller K; Khalili H
Clin Gastroenterol Hepatol; 2021 May; 19(5):895-907.e4. PubMed ID: 32835841
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
Chhibba T; Guizzetti L; Seow CH; Lu C; Novak KL; Ananthakrishnan AN; Bernstein CN; Kaplan GG; Panaccione R; Ma C
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2064-2071.e1. PubMed ID: 32683099
[TBL] [Abstract][Full Text] [Related]
5. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
7. De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.
Rabinowitz LG; Zylberberg HM; Yang J; Gold SL; Chesner J; Ji J; Hu L; Dubinsky M
Dig Dis Sci; 2022 Aug; 67(8):4033-4042. PubMed ID: 34613501
[TBL] [Abstract][Full Text] [Related]
8. Delays Related to Prior Authorization in Inflammatory Bowel Disease.
Constant BD; de Zoeten EF; Stahl MG; Vajravelu RK; Lewis JD; Fennimore B; Gerich ME; Scott FI
Pediatrics; 2022 Mar; 149(3):. PubMed ID: 35190811
[TBL] [Abstract][Full Text] [Related]
9. Impact of sex and socioeconomic status on the likelihood of surgery, hospitalization, and use of medications in inflammatory bowel disease: a systematic review and meta-analysis.
Rasmussen NF; Moos C; Gregersen LHK; Hikmat Z; Andersen V; Green A; Jess T; Madsen GI; Pedersen AK; Petersen SR; Kjeldsen LJ
Syst Rev; 2024 Jun; 13(1):164. PubMed ID: 38915086
[TBL] [Abstract][Full Text] [Related]
10. Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease.
Szigethy EM; Murphy SM; Ehrlich OG; Heller CA; Engel-Nitz NM; Meadows P; Allen JI
Crohns Colitis 360; 2021 Apr; 3(2):otab021. PubMed ID: 36778940
[TBL] [Abstract][Full Text] [Related]
11. Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
Berry SK; Takakura W; Bresee C; Melmed GY
Dig Dis Sci; 2020 Jun; 65(6):1777-1783. PubMed ID: 31654314
[TBL] [Abstract][Full Text] [Related]
12. Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and Opioids.
Keefer L; Gorbenko K; Siganporia T; Manning L; Tse S; Biello A; Ungaro R; Cohen LJ; Cohen BL; Dubinsky MC
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1831-1838. PubMed ID: 34798332
[TBL] [Abstract][Full Text] [Related]
13. Significant Racial and Ethnic Disparities Exist in Health Care Utilization in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Tandon P; Chhibba T; Natt N; Singh Brar G; Malhi G; Nguyen GC
Inflamm Bowel Dis; 2024 Mar; 30(3):470-481. PubMed ID: 36975373
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease - a population-based self-controlled case series analysis.
Lee JJY; Bernatsky S; Benchimol EI; Kuenzig ME; Kwong JC; Li Q; Widdifield J
BMC Gastroenterol; 2024 May; 24(1):189. PubMed ID: 38816836
[TBL] [Abstract][Full Text] [Related]
15. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
Dubinsky MC; Dotan I; Rubin DT; Bernauer M; Patel D; Cheung R; Modesto I; Latymer M; Keefer L
Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):985-997. PubMed ID: 34130572
[TBL] [Abstract][Full Text] [Related]
16. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Tripathi K; Godoy Brewer G; Thu Nguyen M; Singh Y; Saleh Ismail M; Sauk JS; Parian AM; Limketkai BN
Inflamm Bowel Dis; 2022 Aug; 28(8):1265-1279. PubMed ID: 34718595
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
Tan MC; El-Serag HB; Hou JK
Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
[TBL] [Abstract][Full Text] [Related]
19. The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.
Anderson A; Click B; Ramos-Rivers C; Koutroubakis IE; Hashash JG; Dunn MA; Schwartz M; Swoger J; Barrie A; Regueiro M; Binion DG
Inflamm Bowel Dis; 2018 Jun; 24(7):1380-1388. PubMed ID: 29860492
[TBL] [Abstract][Full Text] [Related]
20. Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis.
Deschamps J; Gilbertson J; Straube S; Dong K; MacMaster FP; Korownyk C; Montgomery L; Mahaffey R; Downar J; Clarke H; Muscedere J; Rittenbach K; Featherstone R; Sebastianski M; Vandermeer B; Lynam D; Magnussen R; Bagshaw SM; Rewa OG
Syst Rev; 2019 Apr; 8(1):88. PubMed ID: 30953550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
